Home > Products > HER2 & MET
> Recombinant Anti-HER2 x Anti-MET sdAb Bispecific Antibody (IgG-sdAb)
Recombinant Anti-HER2 x Anti-MET sdAb Bispecific Antibody (IgG-sdAb) (CAT#: IGVHH-048)
Recombinant Anti-HER2 x Anti-MET Bispecific Antibody (IgG-sdAb) is designed to be expressed as a LC and an extended HC with a sdAb linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy. As required, the sdAb can also be fused to the C terminus of the LC.
There are currently no customer reviews or questions for Recombinant Anti-HER2 x Anti-MET sdAb Bispecific Antibody (IgG-sdAb) (IGVHH-048). Click the button below to contact us or submit your feedback about this product.